Israeli company Can-Fite Biopharma, which develops and commercializes advanced clinical drugs for inflammatory and liver diseases, has raised approx. $6 million in an Initial Public Offering held on Wall Street. Next, the company is planning a public offering on the New York Stock Exchange.
Related posts
Israeli Pineapple-Based Burn Therapy Treating Injured US Troops
October 02, 2023
AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023
Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023
Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Facebook comments